|
|
|
|
| LEADER |
02481nam a22004215i 4500 |
| 001 |
978-0-306-47932-8 |
| 005 |
20191022161447.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2003 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780306479328
|
| 024 |
7 |
|
|a 10.1007/b105364
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Polymer Drugs in the Clinical Stage
|b Advantages and Prospects /
|c edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano.
|
| 250 |
|
|
|a 1st ed. 2003.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2003.
|
| 300 |
|
|
|a VIII, 226 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 519
|
| 505 |
0 |
|
|a Challenges in Polymer Therapeutics -- Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS -- PEG-Adenosine Deaminase and PEG-Asparaginase -- Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C -- PEG-Methioninase -- Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate -- HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer -- Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer -- CM-Dextran-Polyalcohol-Camptothecin Conjugate -- Polymeric Micelle Drug Carrier Systems: PEG-PAsp(Dox) and Second Generation of Micellar Drugs -- An Interim Analysis of Phase I Clinical Trial of MCC-465, a Doxorubicin (DXR) Encapsulated in PEG-immunoliposome, in Patients with Metastatic Stomach Cancer -- Polymer Conjugates for Imaging -- S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative as a Candidate Material for Oxygen Therapeutics.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Polymers .
|
| 650 |
|
0 |
|a Medical biochemistry.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
|
0 |
|a Pharmacy.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Polymer Sciences.
|
| 650 |
2 |
4 |
|a Medical Biochemistry.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Pharmacy.
|
| 700 |
1 |
|
|a Maeda, Hiroshi.
|e editor.
|
| 700 |
1 |
|
|a Kabanov, Alexander.
|e editor.
|
| 700 |
1 |
|
|a Kataoka, Kazunori.
|e editor.
|
| 700 |
1 |
|
|a Okano, Teruo.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/b105364
|